Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.
نویسندگان
چکیده
Self-injurious ideation or behavior appeared de novo or intensified during fluoxetine treatment of obsessive-compulsive disorder in six patients, age 10 to 17 years old, who were among 42 young patients receiving fluoxetine for obsessive-compulsive disorder at a university clinical research center. These symptoms required the hospitalization of four patients. Before receiving fluoxetine, four patients had major risk factors for self-destructive behavior including depression or prior suicidal ideation or self-injury. Three hypotheses concerning the apparent association between fluoxetine and these self-injurious phenomena are discussed: (1) coincidence; (2) disorganization of vulnerable individuals secondary to drug-induced activation; and (3) a specific serotonergic-mediated effect on the regulation of aggression.
منابع مشابه
Facing the evidence: antidepressant treatment in children and adolescents.
from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Safety Medicine 2003/2004;16:5-19. Available: www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf (accessed 2004 Jan 26). 10. Medawar C, Herxheimer A, Bell A, Jofre S. Paroxetine, Panorama and user reporting of ADRs: consumer intelligence matters in clinical practice and postmarketing d...
متن کاملاثر فلوکستین بر اختلال بیشفعالی- کمتوجهی: یک بررسی مقدماتی
Abstract Introduction: This study was aimed to determine the efficacy of fluoxetine in treating attention-deficit hyperactivity disorder (ADHD) in children and adolescents. Method: Twenty-two children and adolescents (6-16 years) diagnosed as having ADHD (excluding mental retardation, comorbid disorders, using concomitant medications) based on clinical psychi-atric evaluation, Diagnostic Inter...
متن کاملThe use of Selective Serotonin Re-uptake Inhibitors (SSRIs) in the treatment of depressive disorders in children and adolescents.
There is a controversy about the use of SSRIs in the treatment of depressive disorders'in children and adolescents. Media concern that SSRIs might precipitate suicidal acts in teenagers was highlighted in a BBC Panorama programme (BBC News, 2003). Shortly afterwards, the pharmaceutical companies GlaxoSmithKline and Wyeth issued warnings about their products Paroxetine and Venlafaxine. In Decemb...
متن کاملContinuing fluoxetine treatment may delay relapse in children and adolescents with major depressive disorder.
Emslie GJ, Heiligenstein JH, Hoog SL, et al. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 2004;43:1397–405. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....
متن کاملFluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.
BACKGROUND This report presents results from the acute treatment phase of a clinical trial designed to confirm efficacy of a fixed dose of 20 mg of fluoxetine in children and adolescents with major depressive disorder (MDD). METHOD After a 3-week screening period, 122 children and 97 adolescents with MDD ( ) were randomly assigned to placebo or fluoxetine. After a 1-week placebo lead-in, fluo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of the American Academy of Child and Adolescent Psychiatry
دوره 30 2 شماره
صفحات -
تاریخ انتشار 1991